Baird Medical Expands into Egypt with First Bone Tumor Ablation
Baird Medical Investment Holdings Ltd. $(BDMD)$, a global leader in minimally invasive Microwave Ablation $(MWA)$ technology, has expanded into the Egyptian market. The company recently completed its first successful bone tumor ablation procedure at Ain Shams Specialized Hospital in Cairo, performed by Dr. Amr Mahmoud. This marks a significant milestone for Baird Medical, showcasing the versatility of its MWA system in treating both soft tissue and bone lesions. The expansion into Egypt underscores the company's commitment to increasing global access to advanced, non-surgical medical solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE13377) on November 03, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。